Moshkelgosha

Target price for Novavax..?

Long
Moshkelgosha Updated   
NASDAQ:NVAX   Novavax, Inc.
Novavax is getting ready to test its all time high at 300, but it could go further.
On April 15th 2020, I made the first call on MRNA, NVAX, and INO, to be the companies which will produce COVID-19 vaccine.After 10 months 2 out of 3 have COVID-19 vaccine on the market!
Ever since MRNA has had 468% and NVAX made a decent 1240% gain just in 9 months
Trade closed: target reached:
Just touched 300

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.